| Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer. | thyroid, |
| TIMP3, DAPK1 and AKR1B10 are important for squamous cell lung cancer tumorogenesis while AKR1B10 is potential oncogene whereas TIMP3 and DAPK1 are potential tumor suppressor genes. | lung, |
| Combined effects of cigarette smoking, gene polymorphisms and methylations of tumor suppressor genes on non small cell lung cancer: a hospital-based case-control study in China. | lung, |
| Promoter hypermethylation of tumor suppressor DAPK1 is associated with prostate carcinoma. | prostate, |
| Data show that silencing DNA methyltransferase 1 (DNMT1) increased expression of tumor suppressor genes, RASSF1A and DAPK, in esophageal squamous cell carcinoma (ESCC) cells and ESCC xenograft in nude mice. | esophageal, |
| KRAS, BRAF oncogene mutations and tissue specific promoter hypermethylation of tumor suppressor SFRP2, DAPK1, MGMT, HIC1 and p16 genes in colorectal cancer patients | colorectal, |
| Results show that DNA demethylation of distinct promoter regions is associated with re-expression of the tumor suppressor gene DAPK1. Its knockdown promotes tumor cell migration in breast cancer cell line. | breast, |
| Epigenetic silencing of the tumor suppressor genes SPI1, PRDX2, KLF4, DLEC1, and DAPK1 in childhood and adolescent lymphomas | lymphoma, |
| The tumor suppressor DAP kinase is a target of RSK-mediated survival signaling. | None |
| The tumor suppressor death-associated protein kinase targets to TCR-stimulated NF-kappa B activation. | None |
| Tumor suppressor death-associated protein kinase is required for full IL-1?? production. | None |
| Tumor suppressor death-associated protein kinase 1 inhibits necroptosis by p38 MAPK activation | None |